Chemours Other Stockholder Equity vs Total Liab Analysis

0HWG Stock

20.05 1.00 4.75%

Chemours financial indicator trend analysis is way more than just evaluating Chemours prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Chemours is a good investment. Please check the relationship between Chemours Other Stockholder Equity and its Total Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Other Stockholder Equity vs Total Liab

Other Stockholder Equity vs Total Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Chemours Other Stockholder Equity account and Total Liab. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Chemours' Other Stockholder Equity and Total Liab is -0.13. Overlapping area represents the amount of variation of Other Stockholder Equity that can explain the historical movement of Total Liab in the same time period over historical financial statements of Chemours Co, assuming nothing else is changed. The correlation between historical values of Chemours' Other Stockholder Equity and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Stockholder Equity of Chemours Co are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Other Stockholder Equity i.e., Chemours' Other Stockholder Equity and Total Liab go up and down completely randomly.

Correlation Coefficient

-0.13

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Other Stockholder Equity

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Most indicators from Chemours' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Chemours current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Tax Provision is likely to gain to about (34.2 M) in 2024. Selling General Administrative is likely to drop to about 465 M in 2024

	2021	2022	2023	2024 (projected)
Total Revenue	6.3B	6.8B	6.0B	5.0B
Depreciation And Amortization	317M	291M	307M	315.2M

Total Revenue Depreciation And Amortization

Chemours fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Net Receivables	Good Will	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Common Stock Shares Outstanding	Short Long Term Debt Total	Current Deferred Revenue	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Non Current Liabilities Total
Total Assets		0.63	0.83	-0.71	0.76	0.55	0.87	0.72	0.71	-0.35	-0.91	0.63	-0.06	-0.48	0.89	0.95	-0.64	-0.83	-0.64	0.49	-0.3	-0.68	0.91	0.87	0.92	0.42
Other Current Liab	0.63		0.81	-0.48	0.34	0.42	0.47	0.49	0.63	-0.38	-0.71	0.41	0.51	-0.44	0.54	0.64	-0.69	-0.52	-0.74	0.32	0.25	-0.67	0.47	0.55	0.69	0.38
Total Current Liabilities	0.83	0.81		-0.6	0.43	0.62	0.62	0.64	0.87	-0.27	-0.89	0.62	0.21	-0.44	0.73	0.86	-0.68	-0.66	-0.61	0.17	0.15	-0.64	0.71	0.68	0.83	0.21
Total Stockholder Equity	-0.71	-0.48	-0.6		-0.47	-0.04	-0.61	-0.65	-0.47	0.06	0.71	-0.08	0.37	-0.1	-0.95	-0.72	0.47	0.97	0.31	-0.17	-0.13	0.6	-0.53	-0.68	-0.66	-0.02
Property Plant And Equipment Net	0.76	0.34	0.43	-0.47		0.25	0.94	0.63	0.31	-0.61	-0.59	0.51	0.0	-0.57	0.62	0.53	-0.53	-0.58	-0.69	0.75	-0.47	-0.24	0.74	0.51	0.52	0.62
Accounts Payable	0.55	0.42	0.62	-0.04	0.25		0.43	0.4	0.66	-0.06	-0.58	0.83	0.31	-0.56	0.26	0.56	-0.46	-0.19	-0.43	0.06	-0.28	-0.46	0.59	0.4	0.45	0.22
Non Current Assets Total	0.87	0.47	0.62	-0.61	0.94	0.43		0.81	0.53	-0.5	-0.74	0.59	-0.01	-0.51	0.76	0.7	-0.7	-0.71	-0.68	0.58	-0.34	-0.42	0.8	0.63	0.64	0.49
Non Currrent Assets Other	0.72	0.49	0.64	-0.65	0.63	0.4	0.81		0.45	-0.08	-0.6	0.3	-0.02	-0.09	0.72	0.65	-0.75	-0.68	-0.35	0.22	-0.01	-0.53	0.51	0.59	0.58	0.13
Other Assets	0.71	0.63	0.87	-0.47	0.31	0.66	0.53	0.45		-0.29	-0.83	0.72	0.17	-0.46	0.61	0.73	-0.65	-0.53	-0.56	0.04	0.05	-0.48	0.66	0.5	0.66	0.15
Net Receivables	-0.35	-0.38	-0.27	0.06	-0.61	-0.06	-0.5	-0.08	-0.29		0.41	-0.44	-0.25	0.81	-0.17	-0.14	0.32	0.15	0.81	-0.52	0.14	0.06	-0.52	-0.17	-0.25	-0.5
Good Will	-0.91	-0.71	-0.89	0.71	-0.59	-0.58	-0.74	-0.6	-0.83	0.41		-0.62	0.05	0.52	-0.85	-0.9	0.68	0.81	0.7	-0.27	0.07	0.74	-0.88	-0.81	-0.87	-0.24
Inventory	0.63	0.41	0.62	-0.08	0.51	0.83	0.59	0.3	0.72	-0.44	-0.62		0.34	-0.81	0.32	0.54	-0.37	-0.23	-0.68	0.34	-0.36	-0.21	0.74	0.32	0.44	0.49
Other Current Assets	-0.06	0.51	0.21	0.37	0.0	0.31	-0.01	-0.02	0.17	-0.25	0.05	0.34		-0.43	-0.31	-0.11	-0.32	0.35	-0.46	0.31	0.05	0.15	-0.15	-0.27	-0.07	0.55
Other Stockholder Equity	-0.48	-0.44	-0.44	-0.1	-0.57	-0.56	-0.51	-0.09	-0.46	0.81	0.52	-0.81	-0.43		-0.13	-0.33	0.31	0.07	0.85	-0.52	0.34	0.16	-0.68	-0.25	-0.36	-0.6
Total Liab	0.89	0.54	0.73	-0.95	0.62	0.26	0.76	0.72	0.61	-0.17	-0.85	0.32	-0.31	-0.13		0.88	-0.56	-0.99	-0.44	0.3	-0.05	-0.67	0.74	0.82	0.82	0.16
Total Current Assets	0.95	0.64	0.86	-0.72	0.53	0.56	0.7	0.65	0.73	-0.14	-0.9	0.54	-0.11	-0.33	0.88		-0.57	-0.83	-0.48	0.33	-0.18	-0.78	0.83	0.93	0.97	0.27
Intangible Assets	-0.64	-0.69	-0.68	0.47	-0.53	-0.46	-0.7	-0.75	-0.65	0.32	0.68	-0.37	-0.32	0.31	-0.56	-0.57		0.51	0.59	-0.3	0.01	0.49	-0.44	-0.48	-0.56	-0.33
Common Stock	-0.83	-0.52	-0.66	0.97	-0.58	-0.19	-0.71	-0.68	-0.53	0.15	0.81	-0.23	0.35	0.07	-0.99	-0.83	0.51		0.42	-0.28	0.03	0.71	-0.7	-0.81	-0.77	-0.13
Common Stock Shares Outstanding	-0.64	-0.74	-0.61	0.31	-0.69	-0.43	-0.68	-0.35	-0.56	0.81	0.7	-0.68	-0.46	0.85	-0.44	-0.48	0.59	0.42		-0.62	0.13	0.37	-0.68	-0.39	-0.51	-0.66
Short Long Term Debt Total	0.49	0.32	0.17	-0.17	0.75	0.06	0.58	0.22	0.04	-0.52	-0.27	0.34	0.31	-0.52	0.3	0.33	-0.3	-0.28	-0.62		-0.62	-0.05	0.44	0.33	0.38	0.94
Current Deferred Revenue	-0.3	0.25	0.15	-0.13	-0.47	-0.28	-0.34	-0.01	0.05	0.14	0.07	-0.36	0.05	0.34	-0.05	-0.18	0.01	0.03	0.13	-0.62		-0.07	-0.39	-0.22	-0.16	-0.59
Net Debt	-0.68	-0.67	-0.64	0.6	-0.24	-0.46	-0.42	-0.53	-0.48	0.06	0.74	-0.21	0.15	0.16	-0.67	-0.78	0.49	0.71	0.37	-0.05	-0.07		-0.59	-0.87	-0.8	0.03
Retained Earnings	0.91	0.47	0.71	-0.53	0.74	0.59	0.8	0.51	0.66	-0.52	-0.88	0.74	-0.15	-0.68	0.74	0.83	-0.44	-0.7	-0.68	0.44	-0.39	-0.59		0.79	0.8	0.37
Cash	0.87	0.55	0.68	-0.68	0.51	0.4	0.63	0.59	0.5	-0.17	-0.81	0.32	-0.27	-0.25	0.82	0.93	-0.48	-0.81	-0.39	0.33	-0.22	-0.87	0.79		0.95	0.19
Cash And Short Term Investments	0.92	0.69	0.83	-0.66	0.52	0.45	0.64	0.58	0.66	-0.25	-0.87	0.44	-0.07	-0.36	0.82	0.97	-0.56	-0.77	-0.51	0.38	-0.16	-0.8	0.8	0.95		0.3
Non Current Liabilities Total	0.42	0.38	0.21	-0.02	0.62	0.22	0.49	0.13	0.15	-0.5	-0.24	0.49	0.55	-0.6	0.16	0.27	-0.33	-0.13	-0.66	0.94	-0.59	0.03	0.37	0.19	0.3

Click cells to compare fundamentals

Chemours Account Relationship Matchups

Chemours fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	7.3B	7.1B	7.6B	7.6B	8.3B	7.5B
Other Current Liab	368M	473M	587M	551M	1.2B	1.3B
Total Current Liabilities	1.5B	1.4B	1.9B	1.9B	2.5B	1.8B
Total Stockholder Equity	689M	813M	1.1B	1.1B	737M	1.1B
Property Plant And Equipment Net	3.9B	3.7B	3.4B	3.4B	3.5B	3.6B
Accounts Payable	901M	820M	1.1B	1.2B	1.1B	1.1B
Non Current Assets Total	4.5B	4.4B	4.2B	4.4B	4.4B	4.4B
Non Currrent Assets Other	252M	310M	276M	371M	677M	710.9M
Other Assets	292M	405M	547M	725M	833.8M	482.6M
Net Receivables	674M	511M	720M	626M	610M	590.9M
Inventory	1.1B	939M	1.1B	1.4B	1.4B	1.2B
Other Current Assets	81M	78M	75M	82M	167M	175.4M
Other Stockholder Equity	(213M)	(182M)	(303M)	(722M)	(773M)	(734.4M)
Total Liab	6.6B	6.3B	6.5B	6.5B	7.5B	5.7B
Total Current Assets	2.8B	2.6B	3.3B	3.2B	3.8B	3.0B
Intangible Assets	28M	21M	14M	6M	3M	2.9M
Common Stock Shares Outstanding	164.8M	166.3M	168.7M	158.3M	148.9M	138.7M
Liabilities And Stockholders Equity	7.3B	7.1B	7.6B	7.6B	8.3B	7.5B
Accumulated Other Comprehensive Income	(349M)	(310M)	(364M)	(343M)	(274M)	(287.7M)
Short Long Term Debt Total	4.5B	4.3B	4.0B	3.9B	4.2B	4.5B
Net Debt	3.5B	3.2B	2.5B	2.8B	3.0B	2.4B
Retained Earnings	1.2B	1.3B	1.7B	2.2B	1.8B	1.2B
Cash	943M	1.1B	1.5B	1.1B	1.2B	1.2B
Cash And Short Term Investments	943M	1.1B	1.5B	1.1B	1.8B	1.3B
Non Current Liabilities Total	5.0B	4.8B	4.6B	4.6B	5.0B	5.2B
Short Term Debt	200M	78M	84M	92M	106M	78.5M
Long Term Debt	4.1B	4.0B	4.0B	3.9B	4.5B	4.3B
Capital Surpluse	837M	860M	859M	890M	1.0B	931.7M
Property Plant Equipment	3.9B	3.7B	3.4B	3.4B	3.9B	3.7B
Other Liab	751M	626M	707M	854M	982.1M	787.4M
Net Tangible Assets	515M	646M	973M	992M	1.1B	853.1M
Deferred Long Term Liab	148M	198M	195M	240M	276M	197.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Chemours Stock Analysis

When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Chemours Other Stockholder Equity vs Total Liab Analysis

Other Stockholder Equity vs Total Liab

Other Stockholder Equity vs Total Liab Correlation Analysis

Correlation Coefficient

Other Stockholder Equity

Total Liab

Chemours fundamental ratios Correlations

Chemours Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Chemours fundamental ratios Accounts

Also Currently Popular

Additional Tools for Chemours Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 0.97	Total Stockholder Equity
Cash And Short Term Investments	+ 0.97	Total Current Assets
Total Current Assets	+ 0.95	Total Assets
Cash And Short Term Investments	+ 0.95	Cash
Non Current Assets Total	+ 0.94	Property Plant And Equipment Net
Non Current Liabilities Total	+ 0.94	Short Long Term Debt Total

Common Stock	- 0.99	Total Liab
Total Liab	- 0.95	Total Stockholder Equity
Good Will	- 0.91	Total Assets
Total Current Assets	- 0.9	Good Will
Good Will	- 0.89	Total Current Liabilities
Retained Earnings	- 0.88	Good Will